{
}
Health stocks fell sharply after President-elect Trump nominated vaccine skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services. The S&P 500 Health Care Index dropped 1.9%, with major companies like Moderna and Pfizer seeing significant losses. Analysts warn that Kennedy's views could undermine vaccine confidence and impact the biotechnology sector, leading to potential public health risks.
The smart healthcare products market is projected to grow from $228.83 billion in 2023 to $439.68 billion by 2028, driven by rising healthcare spending and technological advancements like AI and telehealth. Key players include major corporations such as Apple, Siemens, and GE Healthcare, with North America leading the market. The increasing demand for personalized and connected healthcare solutions is shaping the industry's future.
UBS has maintained a "Neutral" rating for Roche, setting a price target of 270 Swiss francs following insights from pharmaceuticals chief Teresa Graham at an investor conference. Analyst Matthew Weston noted Roche's confidence in achieving sustainable, currency-adjusted growth of 9 percent.
The election of Donald Trump has led to a stronger dollar, which could benefit some of Europe's major exporters despite potential tariffs in a second term. Companies like Roche Holding AG and Ashtead Group Plc, generating 46% and 86% of their revenue in dollars respectively, may find some protection from this currency strength.
UBS has maintained a 'Neutral' rating for Roche, setting a price target of 270 francs. Analyst Matthew Weston noted that recent interim results highlight the superior safety profile of the Alzheimer's antibody trontinemab. The last closing price was 276.30 CHF, with an average target price of 303.76 CHF, indicating a potential upside of 9.94%.
Roche Holding AG reported the death of an elderly patient in a clinical trial for its experimental Alzheimer’s treatment, leading to modifications in the trial design. Despite this incident, the company indicated that overall results support continued testing, highlighting the drug's ability to rapidly eliminate a toxic protein while minimizing common side effects associated with existing therapies.
UBS has maintained a "Neutral" rating for Roche, setting a target price of 270 francs, following a third quarter that slightly exceeded expectations. Analyst Matthew Weston noted that the company's growth drivers remain on track, reflecting a positive outlook for its Pharmaceuticals and Diagnostics divisions.
Roche Holding AG reported a 9% increase in third-quarter sales, reaching 15.1 billion Swiss francs ($17.5 billion), driven by the success of its eye drug Vabysmo and treatments for cancer, hemophilia, and multiple sclerosis. This figure surpassed analysts' average estimate of 14.9 billion francs.
The SPI index on the Zurich Stock Exchange fell 0.18% to 16,103.02 points at midday, marking a weekly decline of 0.974%. Over the past year, the index has risen by 10.52%, with a current high of 16,557.98 points and a low of 14,455.60 points. Notable gainers include Schlatter Industries and Rieter, while HOCHDORF and Evolva are among the biggest losers.
On Wednesday, the SPI index in Zurich fell 0.20% to 16,099.50 points, marking a decline of 0.996% since the start of the week. The index has risen 10.50% year-to-date, with a high of 16,557.98 points and a low of 14,455.60 points recorded this year. Schlatter Industries and Rieter led the gains, while HOCHDORF and Evolva faced significant losses.
Roche Holding AG
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
health stocks decline after trump nominates vaccine skeptic robert f kennedy jr
United States Dollar
Sanofi
Eli Lilly and Company
GSK plc
Novo Nordisk A/S
Roche Holding AG
Pfizer Inc.
USA
GBR
FRA
Brian Abrahams
Robert F. Kennedy Jr.
Michael Yee
Emmanuel Papadakis
Show more
22:25 15.11.2024
smart healthcare products market poised for rapid growth and innovation
United States Dollar
Becton Dickinson and Company
Novartis AG
McKesson Corporation
Koninklijke Philips N.V.
Abbott Laboratories
Olympus Corporation
GE HealthCare Technologies Inc.
Terumo Corporation
Medtronic plc
Samsung Healthcare
FUJIFILM Holdings Corporation
Roche Holding AG
Given Imaging Inc.
Johnson & Johnson
Stryker Corporation
International Business Machines Corporation
Cerner Corporation
ResMed Inc.
Siemens Healthineers AG
Cisco Systems, Inc.
Honeywell Life Care Solutions
AT&T Inc.
Zimmer Biomet Holdings, Inc.
General Electric Company
Cardinal Health, Inc.
OMRON Corporation
Oracle Corporation
Apple Inc.
Brooks Automation Inc.
Agfa-Gevaert Group
Microsoft Corporation
Allscripts Healthcare Solutions Inc.
Boston Scientific Corporation
Cognizant Technology Solutions India Private Limited
Show more
12:08 14.11.2024
ubs maintains neutral rating for roche with target price of 270 francs
14:51 13.11.2024
strong dollar offers benefits for european exporters amid trump uncertainty
10:54 07.11.2024
ubs maintains neutral rating on roche with target price of 270 francs
12:54 30.10.2024
Roche reports patient death in Alzheimer’s trial but supports further testing
08:45 30.10.2024
ubs maintains neutral rating for roche with target price of 270 francs
11:58 23.10.2024
Roche reports strong sales growth driven by new drug portfolio
07:14 23.10.2024
spi index declines as top stocks show mixed performance
Euro
Swiss Franc
Julius Bär Gruppe AG
Adecco Group AG
UBS Group AG
Roche Holding AG
EFG International AG
CHE
Show more
09:00 02.10.2024
spi index declines as trading volume shifts among top stocks
Euro
Swiss Franc
Julius Bär Gruppe AG
Adecco Group AG
UBS Group AG
Roche Holding AG
EFG International AG
CHE
Show more
09:00 02.10.2024
Trending
Subcategory
Corporate News
Industry Trends
Startups & Entrepreneurship
Retail and Consumer Goods
Supply Chain Management
Global Trade Developments
Stock Market Updates
Government Economic Policies
Industry Mergers & Acquisitions
Energy Sector Developments
Workplace Trends
Funding Rounds & Investments
CEO Changes
AI Applications
Private Equity Deals
Emerging Startups
Fintech Startups
AI Innovations
Global Financial Events
Central Bank Actions
Countries:
Companies:
Apple Inc.
Google Inc.
Tesla, Inc.
Amazon.com, Inc.
Microsoft Corporation
Tesmec S.p.A.
Alphabet Inc.
OpenAI ERC USD
Walmart Inc.
SWIGGY LIMITED
TENCENT
NVIDIA Corporation
Foxconn Technology Co., Ltd.
Hollywood Bowl Group PLC
NASDAQ Composite
Wise plc
Mastercard Inc
Bose Corporation
Mistral 1
Fast Retailing Co., Ltd.
Currencies:
United States Dollar
Indian Rupee
Chinese Yuan
Euro
British Pound Sterling
Japanese Yen
United Arab Emirates Dirham
Vietnamese Đồng
South Korean Won
New Zealand Dollar
Saudi Riyal
Thai Baht
Australian Dollar
Indonesian Rupiah
Singapore Dollar
Omani Rial
Bahraini Dinar
Qatari Riyal
Algerian Dinar
Egyptian Pound
People: